The clinical value of serum prealbnmin in patienis with chronic schistosome
10.3760/cma.j.issn.1000-4955.2012.03.028
- VernacularTitle:慢性血吸虫患者血清前白蛋白的临床价值
- Author:
Sheng-qiang, XU
;
Sheng-yong, YUAN
- Publication Type:Journal Article
- Keywords:
Schistosomiasis;
Prealbumin;
Serologic tests
- From:Chinese Journal of Endemiology
2012;31(3):336-337
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo observe the clinical value of serum prealbumin in patients with chronic schistosome.Methodsone hundred and twenty six patients with chronic schistosome in the Gastroenterology Department and 40 healthy people in the Physical Examination Center of the First Hospital of Wuhan were enrolledin the study.Serum prealbumin(PA) and albumin(ALB) in healthy controls and patients with chronic schistosome before therapy and 1 st,2 nd,4 th weeks after therapy were detected and analyzed.ResultsBefore therapy,PA and ALB [(223.9 ± 43.2)mg/L, (41.5 ± 5.8)g/L] of patient group were lower than that of the control group [(314.5 ± 53.6)mg/L,(47.2 ± 6.9)g/L,t =4.527,2.786,respectively,all P＜ 0.05].After therapy,PAs of patient group at the 1 st,2 nd,4 th weeks [(245.8 ± 41.7),(258.3 ± 47.2),(282.9 ± 49.3)mg/L] were higher than that before the therapy (t =3.092,3.789,4.230,all P ＜ 0.05).ALB of patient group at the 1 st,2 nd,4 th weeks [(41.1 ± 4.7),(41.4 ± 5.2),(44.8 ± 4.5)g/L] were not significantly different compaired to that before therapy(t =0.123,0.119,0.156,all P ＞ 0.05).ConclusionsPrealbumin could quickly and sensitively respond to the changes of liver function.It could be used in the judgment of curative effect and prognosis of patients with schistosome.
